1.
Jfri A, Meltzer R, Guggina L. Runner Up: Incidence of Cutaneous Adverse Events with PI3K-Akt-mTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis. J of Skin [Internet]. 2022May6 [cited 2022Jun.29];6(3):s39. Available from: https://jofskin.org/index.php/skin/article/view/1580